Case Study: Using Technology To Reduce Operational Burden In Clinical Research

In 2016, the Leukemia and Lymphoma Society (LLS) established the Beat AML® Master Trial with the aim of advancing the treatment paradigm for Acute Myeloid Leukemia (AML) through collaboration across over 20+ sites, sponsors, and technology vendors.
By deploying Flatiron’s clinical trial solutions, including Flatiron Clinical Pipe™, sites were able to transfer data with 100% accuracy over the course of the trial. Learn more about how LLS partnered with Flatiron to meet the high demands and standards for Beat AML®.
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Hydrocarbon Online? Subscribe today.
Subscribe to Hydrocarbon Online
X
Subscribe to Hydrocarbon Online
Flatiron Health
This website uses cookies to ensure you get the best experience on our website. Learn more